Literature DB >> 10943633

Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?

R F Miller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10943633      PMCID： PMC1765936          DOI： 10.1136/thorax.55.suppl_1.s15

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  39 in total

Review 1.  The treatment of tuberculosis in HIV-infected persons.

Authors:  A L Pozniak; R Miller; L P Ormerod
Journal:  AIDS       Date:  1999-03-11       Impact factor: 4.177

2.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

3.  A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)

Authors:  W M El-Sadr; R Luskin-Hawk; T M Yurik; J Walker; D Abrams; S L John; R Sherer; L Crane; A Labriola; S Caras; C Pulling; R Hafner
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

4.  Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

Authors:  J N Martin; D A Rose; W K Hadley; F Perdreau-Remington; P K Lam; J L Gerberding
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

5.  Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

Authors:  H R Brodt; B S Kamps; P Gute; B Knupp; S Staszewski; E B Helm
Journal:  AIDS       Date:  1997-11-15       Impact factor: 4.177

6.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

7.  Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1.

Authors:  A D Pitkin; A D Grant; N M Foley; R F Miller
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

Review 8.  Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?

Authors:  P P Koopmans; A J van der Ven; T B Vree; J W van der Meer
Journal:  AIDS       Date:  1995-03       Impact factor: 4.177

9.  The scid mouse as an experimental model for the evaluation of anti-Pneumocystis carinii therapy.

Authors:  S Kunz; U Junker; J Blaser; B Joos; B Meyer; O Zak; T O'Reilly
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

Review 10.  Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.

Authors:  M A Jacobson; M French
Journal:  AIDS       Date:  1998       Impact factor: 4.177
View more
  1 in total

1.  Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.

Authors:  Robert F Miller; Austin R Lindley; Helen E Ambrose; Adam S Malin; Ann E Wakefield
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.